Anti-cancer drug approved based on a surrogate endpoint
Publié le
Surrogate endpoint for overall survival We managed to prove, using data from a randomized trial comparing Ceplene + IL-2 to…
Publié le
Surrogate endpoint for overall survival We managed to prove, using data from a randomized trial comparing Ceplene + IL-2 to…
Publié le
Free Webinar on Biomarker-Based Clinical Trial Designs The webinar on biomarker-based clinical trial designs reviewed of the recently proposed-designs, including adaptive…
Publié le
IDDI organized its first free live webinar on STATISTICAL VALIDATION OF BIOMARKERS WATCH RECORDED WEBINAR TO ACCESS THE PRESENTATION OF THIS…
Publié le
IDDI organized its second free live webinar on DEVELOPMENT AND VALIDATION OF CLINICALLY USEFUL GENE SIGNATURES. This webinar reviewed statistical issues…
Publié le
IDDI organized a webinar on Operational Aspects of Data Monitoring Committees. The webinar explored best practices that have emerged during this…
Publié le
Job Description: The Project Manager is the key client contact for projects where IDDI is performing multiple tasks (randomization, data…
Publié le
A multi-center phase II trial was conducted in just over 100 patients to compare metabolic changes in the prostate after…
Publié le
IDDI had very responsive and professional team. Flexibility is a great asset of the team! IDDI has performed data management for…
Publié le
IDDI organized a webinar on DESIGN AND ANALYSIS OF PHASE II TRIALS IN ONCOLOGY. This webinar presented key concepts and…
Publié le
IDDI, announces that it has signed a collaborative agreement with I-BioStat, the Interuniversity Institute for Biostatistics and statistical Bioinformatics, which…